This is understandable, as many people have struggled with weight and associated medical issues for most of their life, and may feel desperate for something that might work, says Stanley
GLP-1 Options: Brand-Name vs
Kisspeptin-52 partially rescues the activity of the hypothalamus-pituitary-gonadal axis in underweight male rats dosed with an anti-obesity compound
However, theyre not for everyoneside effects, cost, and accessibility can be barriers
Established GLP-1 medications provide clearer evidence for older adults
doi: 10.1007/s12020-021-02730-0 Summary Keywords growth hormone, insulin-like growth factor, GLP-1RAs, SGLT-2is, diabetes Citation Cignarelli A, Genchi VA, Le Grazie G, Caruso I, Marrano N, Biondi G, DOria R, Sorice GP, Natalicchio A, Perrini S, Laviola L and Giorgino F (2022) Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis